Biotechgate Digital Partnering, virtual, November 2020, 23 pages Presentation
Author: Biotechgate
Identifying Recently Funded Biotech Companies in Biotechgate
Looking to identify new Biotech companies that may require your contract research, manufacturing or similar services can be a time-consuming task. The Biotechgate database provides details of over 59,000 companies worldwide and more than 90,000 assets. Crucially, we track over 21,000 financing rounds from initial seed funding to post-IPO for biotech companies all around the … Continue reading Identifying Recently Funded Biotech Companies in Biotechgate
Life science asset database
We regularly hear about new licensing agreements between pharmaceutical and biotech companies. These usually involve assets – such as therapeutics, diagnostics, medical devices or technologies – which are to be developed or marketed together. A big challenge however is to find the right partner for the right asset. The Biotechgate database features almost 90,000 life … Continue reading Life science asset database
Launch of the Life Science Directory for Medicen Paris
Media Release Launch of the Life Science Directory for Medicen Paris Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe. Venture Valuation/Biotechgate … Continue reading Launch of the Life Science Directory for Medicen Paris
Canadian Life Science Market Trend Analysis 2020
Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.
German Life Science Market Trend Analysis 2020
This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN. With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted … Continue reading German Life Science Market Trend Analysis 2020
Dutch Life Science Market Trend Analysis 2020
Biotechgate presents the annual Trend Analysis Report 2020 for the Dutch life sciences sector. The report shows a stable number of life science companies and a sector which has grown in maturity. Biotech companies were successful in attracting venture capital; 2019 is a record year for venture financing.
Denmark Life Science Market Trend Analysis 2020
The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the … Continue reading Denmark Life Science Market Trend Analysis 2020
Korean Life Science Market Trend Analysis 2020
South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our … Continue reading Korean Life Science Market Trend Analysis 2020
Swiss Life Science Market Trend Analysis 2020
Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.